Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.62 -0.01 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Other Accumulated Expenses (2024 - 2026)

Updated

Biodexa Pharmaceuticals (BDRX) reported Other Accumulated Expenses of $817,082 for the quarter ended Jun 30, 2026, up 17.3% from $696,372 a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Biodexa Pharmaceuticals posted Other Accumulated Expenses of $742,321, up 7.9% from the prior year.

  • By year, Other Accumulated Expenses came in at $687,712 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Biodexa Pharmaceuticals 39.17 Mn 15.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 817,082.21
Dec 31, 2025 748,883.57
Jun 30, 2025 696,371.85
Dec 31, 2024 690,523.99
Jun 30, 2024 579,359.32
API Access

Biodexa Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BDRX&period=max&api_key=YOUR_API_KEY